© Reuters. FILE PHOTO: Vials labelled “Astra Zeneca COVID-19 Coronavirus Vaccine” and a syringe are seen in entrance of a displayed AstraZeneca brand on this illustration photographCOPENHAGEN (Reuters) – A 60-year previous Danish lady who died of a blood clot after receiving AstraZeneca (NASDAQ:)’s COVID-19 vaccine had “extremely uncommon” signs, the Danish Medicines Company stated late on Sunday.
It stated the lady had a low variety of blood platelets and clots in small and enormous vessels, in addition to bleeding.
European vaccination programmes have been upset within the final two weeks by reviews that recipients of the AstraZeneca inoculation have suffered blood clots.
The European Medicines Company has stated there is no such thing as a indication that the occasions had been brought on by the vaccination, a view that was echoed by the World Well being Group on Friday.
AstraZeneca Plc stated on Sunday a evaluate of security information of individuals vaccinated with its COVID-19 vaccine has proven no proof of an elevated threat of blood clots.
Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or harm on account of reliance on the knowledge together with information, quotes, charts and purchase/promote alerts contained inside this web site. Please be absolutely knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding varieties attainable.
